Rare Patient Voice, founded in 2013 and based in the United States, operates within the Business Services sector, specifically focusing on advertising and marketing, corporate services, and market research. The company engages in research related to the rare disease community, as evidenced by its published white paper on mental health and rare diseases. This document highlights the significant emotional distress experienced by patients and caregivers, with findings indicating that 82.4% of participants report frequent emotional challenges that affect their daily lives. The white paper emphasizes the interconnectedness of mental and physical health in treatment adherence and overall patient outcomes, advocating for a holistic approach to care that addresses emotional, social, and practical needs. Rare Patient Voice aims to bridge the gap in mental health support within the rare disease community by providing actionable recommendations for healthcare providers, patient advocacy groups, and pharmaceutical companies. The company employs between 51 and 200 individuals and reported revenue of approximately $4.7 million.